JNK1 is required for T cell-mediated immunity against Leishmania major infection

Journal of Immunology

Volumn 165, Issue 5, 2000, Pages 2671-2676

  Constant, S L ^a   Dong, C ^a   Yang, D D ^a   Wysk, M ^a   Davis, R J ^a   Flavell, R A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; MITOGEN ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; DELAYED HYPERSENSITIVITY; HELPER CELL; LEISHMANIA MAJOR; LEISHMANIASIS; LYMPH NODE CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

EID: 0034283665     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.5.2671     Document Type: Article

References (28)

1. + T lymphocytes
2. Immunity to infection: Lessons on the immune response from the war on bugs
3. The regulation of immunity to Leishmania major
4. Macrophage activation by interferon-γ from host-protective T cells is inhibited by interleukin (IL) 3 and IL 4 produced by disease-promoting T cells in leishmaniasis
5. Interleukin-4 transgenic mice of resistant background are susceptible to Leishmania major infection
6. + T cell responses: The alternative approaches
7. Cell fate decision: Th1 and Th2 subsets in immune responses
8. Regulation of naive T cell differentiation by varying the potency of TCR signal transduction
9. Signal transduction by the c-Jun N-terminal kinase (JNK)-from inflammation to development
10. JNK is involved in signal integration during costimulation of T lymphocytes
11. AP-1 transcriptional activity requires both T-cell receptor-mediated and co-stimulatory signals in primary T lymphocytes
12. Transcriptional regulation in the immune system: All roads lead to AP-1
13. Defective T cell differentiation in the absence of Jnk1
14. IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development an experimental leishmaniasis
15. Leishmania major-infected C3H mice treated with anti-IL-12 mAb develop but do not maintain a Th2 response
16. Defective IL-12 production in mitogen-activated protein (MAP) kinase kinase 3 (Mkk3)-deficient mice
17. Susceptibility to Leishmania major infection in interleukin-4-deficient mice
18. Mouse IL-13 enhances antibody production in vivo and acts directly on B cells in vitro to increase survival and hence antibody production
19. IL-13 is a susceptibility factor for Leishmania major infection
20. IL-4- and IL-4 receptor-deficient BALB/c mice reveal differences in susceptibility to Leishmania major parasite substrains
21. Differences between IL-4 and IL-4 receptor α-deficient mice in chronic leishmaniasis reveal a protective role for IL-13 receptor signaling
22. Interleukin-4 and interleukin-10 synergize to inhibit cell-mediated immunity in vivo
23. JNK inhibits substrate targeting by protein phosphatase calcineurin to NFATcl
24. The transcription factor NFATcl regulates lymphocyte proliferation and Th2 development
25. Delayed lymphoid repopulation with defects in IL-4 driven responses produced by inactivation of NFATc
26. Down-regulation of IL-4 gene transcription and control of Th2 cell differentiation by a mechanism involving NFAT1
27. Hyperproliferation and dysregulation of IL-4 expression in NF-ATp-deficient mice
28. Redundant expression but selective utilization of nuclear factor of activated T cells family members